Gastrointestinal Tract News and Research

RSS

Carnegie professor receives NIH Director's New Innovator Award

Kathryn Whitehead, assistant professor of chemical engineering at Carnegie Mellon University, has been awarded a 2018 National Institutes of Health (NIH) Director's New Innovator Award for her project titled "Fate, Function, and Genetic Engineering of Breast Milk Cells for Infant Therapy."

3 Oct 2018

Daily low-dose aspirin does not prolong healthy life in older people, study finds

In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability).

17 Sep 2018

Innovative robotic system helps in removing large colorectal lesions without surgery

Each year, an estimated 140,000 individuals in the U.S. are diagnosed with colorectal cancer, a malignancy that often develops from a benign polyp into cancer over time.

7 Sep 2018

KU Leuven study: Macrophages in the intestine can survive for a long time

Macrophages are specialized immune cells that destroy bacteria and other harmful organisms. KU Leuven scientists, Belgium, have come to the surprising conclusion that some macrophages in the intestines of mice can survive for quite some time.

30 Aug 2018

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

Routine oral care to treat gum disease may play a role in reducing inflammation and toxins in the blood and improving cognitive function in people with liver cirrhosis.

29 Aug 2018

Newly discovered target may prevent progression of liver injury to cancer

Problems like obesity and alcoholism appear to chronically trigger in the liver a receptor known to amplify inflammation in response to invaders like bacteria, scientists report.

27 Aug 2018

Aspirin appears to cause major bleeds and have no effect on cancers

Aspirin prevented serious vascular events in patients with diabetes who did not already have cardiovascular disease, but it caused almost as many major bleeds and there was no effect on cancers.

27 Aug 2018

Research uncovers unexpected upside of E. coli

Best known as a pathogen that causes food poisoning or steals nutrients away from its host, the E. coli bacterium actually plays a critical role in promoting health by producing a compound that helps cells take up iron, new CU Boulder research shows.

24 Aug 2018

Individual hypertensive responses to antibiotics may vary depending on genetic makeup and gut bacteria

Individual variations in genetic makeup and gut bacteria may explain the different effects of antibiotics on blood pressure, a new rat study suggests. The findings are published ahead of print in Physiological Genomics.

23 Aug 2018

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Dr. Lesley Ann Saketkoo, an associate professor of clinical medicine at Tulane University School of Medicine, has been named Doctor of the Year by the Scleroderma Foundation. The award recognizes leadership and commitment to the community battling scleroderma, a disabling and life-limiting multi-organ autoimmune disease with progressive lung, heart, kidney, gastrointestinal tract and/or vascular involvement.

21 Aug 2018

Strawberries could mitigate colonic inflammation

Inflammatory bowel disease is a set of painful conditions that can cause severe diarrhea and fatigue. Treatments can include medications and surgery. But now researchers report that a simple dietary intervention could mitigate colonic inflammation and improve gut health.

20 Aug 2018

Seeking solutions to treat scleroderma

It begins with cold hands. Not just put-on-some-gloves cold. Instead, the fingers overreact to cold by turning white or blue and may become numb or tingly.

17 Aug 2018

Eating white button mushrooms could improve regulation of glucose in the liver

Eating white button mushrooms can create subtle shifts in the microbial community in the gut, which could improve the regulation of glucose in the liver, according to a team of researchers.

16 Aug 2018

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.

14 Aug 2018

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.

10 Aug 2018

Helmholtz Zentrum München appoints Professor Matthias Tschöp as new CEO

Professor Matthias Tschöp, MD, has been appointed the new CEO of Helmholtz Zentrum München. He took over from Professor Günther Wess, who led the center for the past 13 years.

10 Aug 2018

New approach identifies genes that help microbes to survive in the human gut

Trillions of tiny microbes and bacteria live in your gut, each with their own set of genes. These gut microbes can have both beneficial and harmful effects on your health, from protecting you against inflammation to causing life-threatening infections.

10 Aug 2018

Researchers modify nanoparticles to improve their uptake in gastrointestinal tract

Nanoparticles show great promise as diagnostic tools and drug delivery agents. The tiny particles, which scientists can modify with drugs, dyes or targeting molecules, can travel in the circulation and squeeze through small spaces into cells and tissues.

9 Aug 2018

Study identifies distinct genetic mutations in appendix cancer that may impact treatment

The rarity of appendix cancer, accounting for less than 1 percent of tumors that originate in the gastrointestinal tract, and the lack of scientific data for this disease means that current treatment guidelines recommend applying therapies to people with appendix cancer that are intended for those with colon cancer.

9 Aug 2018

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Probiotic use can result in a significant accumulation of bacteria in the small intestine that can result in disorienting brain fogginess as well as rapid, significant belly bloating, investigators report.

6 Aug 2018

Gastrointestinal Tract News and Research

Carnegie professor receives NIH Director's New Innovator Award

Daily low-dose aspirin does not prolong healthy life in older people, study finds

Innovative robotic system helps in removing large colorectal lesions without surgery

KU Leuven study: Macrophages in the intestine can survive for a long time

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

Newly discovered target may prevent progression of liver injury to cancer

Aspirin appears to cause major bleeds and have no effect on cancers

Research uncovers unexpected upside of E. coli

Individual hypertensive responses to antibiotics may vary depending on genetic makeup and gut bacteria

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Strawberries could mitigate colonic inflammation

Seeking solutions to treat scleroderma

Eating white button mushrooms could improve regulation of glucose in the liver

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

Helmholtz Zentrum München appoints Professor Matthias Tschöp as new CEO

New approach identifies genes that help microbes to survive in the human gut

Researchers modify nanoparticles to improve their uptake in gastrointestinal tract

Study identifies distinct genetic mutations in appendix cancer that may impact treatment

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News